MXPA01008348A - Microcapsulas para la liberacion prolongada de farmacos. - Google Patents

Microcapsulas para la liberacion prolongada de farmacos.

Info

Publication number
MXPA01008348A
MXPA01008348A MXPA01008348A MXPA01008348A MXPA01008348A MX PA01008348 A MXPA01008348 A MX PA01008348A MX PA01008348 A MXPA01008348 A MX PA01008348A MX PA01008348 A MXPA01008348 A MX PA01008348A MX PA01008348 A MXPA01008348 A MX PA01008348A
Authority
MX
Mexico
Prior art keywords
microcapsules
drugs
sustained release
lacticcoglycolic
softener
Prior art date
Application number
MXPA01008348A
Other languages
English (en)
Inventor
Duena Parente Antonio
Original Assignee
Lipotec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec Sa filed Critical Lipotec Sa
Publication of MXPA01008348A publication Critical patent/MXPA01008348A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/22—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Microcapsulas para la liberacion lenta de farmacos, que estan constituidas por un copolimero lactico-co-glicolico, al que se ha incorporado un plastificante y que contienen en su interior un farmaco de interes farmaceutico.
MXPA01008348A 1999-12-17 2000-12-15 Microcapsulas para la liberacion prolongada de farmacos. MXPA01008348A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009902768A ES2169980B1 (es) 1999-12-17 1999-12-17 Microcapsulas para la liberacion prolongada de farmacos.
PCT/ES2000/000475 WO2001043724A1 (es) 1999-12-17 2000-12-15 Microcapsulas para la liberacion prolongada de farmacos

Publications (1)

Publication Number Publication Date
MXPA01008348A true MXPA01008348A (es) 2004-03-19

Family

ID=8310957

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01008348A MXPA01008348A (es) 1999-12-17 2000-12-15 Microcapsulas para la liberacion prolongada de farmacos.

Country Status (13)

Country Link
US (3) US20020187196A1 (es)
EP (1) EP1151746B1 (es)
JP (1) JP5021880B2 (es)
AT (1) ATE234608T1 (es)
AU (1) AU774680B2 (es)
BR (1) BRPI0008197B8 (es)
CA (1) CA2362769C (es)
DE (1) DE60001717T2 (es)
DK (1) DK1151746T3 (es)
ES (2) ES2169980B1 (es)
MX (1) MXPA01008348A (es)
PT (1) PT1151746E (es)
WO (1) WO2001043724A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040097419A1 (en) * 2002-11-19 2004-05-20 Holger Petersen Organic compounds
WO2006123360A2 (en) * 2005-03-01 2006-11-23 Sun Pharmaceutical Industries Limited Microspheres containing octreotide acetate
KR20130024987A (ko) * 2005-12-22 2013-03-08 노파르티스 아게 옥트레오티드 및 ２종 이상의 폴리락티드-코-글리콜리드 중합체를 포함하는 서방형 제제
ES2324009B1 (es) * 2007-11-23 2010-05-21 Gp Pharm S.A. Composicion farmaceutica de liberacion sostenida de somatostatina o un analogo suyo.
KR102039494B1 (ko) * 2011-12-22 2019-11-01 라이프 테크놀로지스 코포레이션 세포 배양 배지 및 방법
CN105267153B (zh) * 2015-11-27 2018-05-11 上海苏豪逸明制药有限公司 一种曲普瑞林缓释微粒及其制备方法
CN110954491B (zh) * 2019-12-09 2022-11-15 北京博恩特药业有限公司 用于测量醋酸戈舍瑞林缓释植入剂体外溶出度的方法
JP7371519B2 (ja) 2020-02-14 2023-10-31 村田機械株式会社 自動倉庫

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2151185A (en) * 1936-01-16 1939-03-21 Carbide & Carbon Chem Corp Esters of glycol monoesters and acylated hydroxy acids
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
WO1981003565A1 (en) 1980-05-29 1981-12-10 H Nicklaus Stringed musical instrument teaching device and process
GB2132887A (en) * 1982-11-15 1984-07-18 Procter & Gamble Enteric-coated anti-inflammatory compositions
CH661206A5 (fr) 1983-09-23 1987-07-15 Debiopharm Sa Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes.
JPS60100516A (ja) 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
DE3678308D1 (de) * 1985-02-07 1991-05-02 Takeda Chemical Industries Ltd Verfahren zur herstellung von mikrokapseln.
JP2551756B2 (ja) 1985-05-07 1996-11-06 武田薬品工業株式会社 ポリオキシカルボン酸エステルおよびその製造法
CH665558A5 (en) 1985-10-09 1988-05-31 Debiopharm Sa Phase sepn. prodn. of microcapsules for water soluble pharmaceuticals - using fluoro-substd. aliphatic hydrocarbon as non-solvent in the hardening stage
GB2209937B (en) 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
CH679207A5 (es) 1989-07-28 1992-01-15 Debiopharm Sa
IT1243390B (it) 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
SE9100610D0 (sv) * 1991-03-04 1991-03-04 Procordia Ortech Ab Bioresorbable material for medical use
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
US5518730A (en) 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
WO1994021237A1 (en) 1993-03-15 1994-09-29 The Board Of Regents Of The University Of Michigan System for controlled release of antiarrhythmic agents
CN1191787C (zh) 1995-10-05 2005-03-09 株式会社东芝 X射线摄像装置
SE505146C2 (sv) * 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning
DE19545257A1 (de) * 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
KR100508229B1 (ko) * 1997-03-18 2005-08-17 선스타 가부시키가이샤 고체 입자 형성용 조성물
GB9718986D0 (en) * 1997-09-09 1997-11-12 Danbiosyst Uk Controlled release microsphere delivery system
US6818018B1 (en) * 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels

Also Published As

Publication number Publication date
BRPI0008197B1 (pt) 2017-05-09
WO2001043724A1 (es) 2001-06-21
US20020187196A1 (en) 2002-12-12
DK1151746T3 (da) 2003-07-21
US9789064B2 (en) 2017-10-17
US20080233198A1 (en) 2008-09-25
BR0008197A (pt) 2002-01-22
CA2362769C (en) 2008-09-09
DE60001717T2 (de) 2004-03-18
ES2169980B1 (es) 2003-11-01
EP1151746B1 (en) 2003-03-19
CA2362769A1 (en) 2001-06-21
ES2194793T3 (es) 2003-12-01
ATE234608T1 (de) 2003-04-15
DE60001717D1 (de) 2003-04-24
ES2169980A1 (es) 2002-07-16
JP2003516960A (ja) 2003-05-20
BRPI0008197B8 (pt) 2021-05-25
JP5021880B2 (ja) 2012-09-12
US20050123618A1 (en) 2005-06-09
EP1151746A1 (en) 2001-11-07
PT1151746E (pt) 2003-07-31
AU2173501A (en) 2001-06-25
AU774680B2 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
PL376099A1 (en) Modified release pharmaceutical composition
WO2000041681A3 (de) ARZNEIFORMULIERUNGEN ENTHALTEND EIN OPIOID UND EINEN α-AGONISTEN
EP1374908A3 (en) Polymer-drug conjugates comprising hydrazide linkers
HUP0301242A3 (en) Controlled release drug dosage form
MXPA03007712A (es) Sales farmaceuticas.
HUP0101237A1 (hu) Elnyújtott kioldódású gyógyszerkészítmények
HK1059565A1 (en) Pharmaceutical compositions for the oral delivery of calcitonin
HRP20010632A2 (en) Matrix tablet enabling prolonged release of gliclazide after administration by the oral route
GEP20063882B (en) Dosage regimen and pharmaceutical composition for emergency contraception
ATE252377T1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
WO2005007137A3 (de) Ambroxolhaltige tabletten
IL150528A0 (en) Ibuprofen containing active agent preparation
MXPA01008348A (es) Microcapsulas para la liberacion prolongada de farmacos.
EP1090639A3 (en) Pharmaceutical composition containing a progestational corticoid and a selective estrogen receptor modulator
ZA200304928B (en) Medicament containing a polyamine as an active substance.
MY128759A (en) Oral controlled release formulations
AU2002224896A1 (en) Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt
AU2502301A (en) Medicament and combination of compatible medicaments
AU2001241067A1 (en) Omega-substituted phenyl-prostaglandin e-alcohols, process for producing the same and drugs containing the same as the active ingredient
WO2001032216A3 (fr) Produit comprenant au moins une substance inhibitrice des no synthases en association avec au moins une substance inhibitrice des phospholipases a2
NO20014889L (no) Fremgangsmåte for fremstilling av medisinske midler
JO2173B1 (en) A tablet block enables increased emission of glycol, further after oral administration
TNSN06298A1 (en) Disintegrating tablets comprising licarbazepine
MX9701873A (es) Formulacion de liberacion prolongada.
ZA200108755B (en) Medicament vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates.

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights